Annals of Oncology

in this issue

in this issue
Ann Oncol 2007 18: 1287; doi:10.1093/annonc/mdm416 [Extract] [Full Text] [PDF] [Request Permissions]  

editorial

S Dawood and M Cristofanilli

Endocrine resistance in breast cancer: what really matters?
Ann Oncol 2007 18: 1289-1291; doi:10.1093/annonc/mdm359 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract PE Lønning, S Knappskog, V Staalesen, R Chrisanthar, and JR Lillehaug

Breast cancer prognostication and prediction in the postgenomic era
Annals of Oncology Advance Access published on February 21, 2007
Ann Oncol 2007 18: 1293-1306; doi:10.1093/annonc/mdm013 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract I Durán, R Salazar, O Casanovas, V Arrazubi, E Vilar, LL Siu, J Yao, and J Tabernero

New drug development in digestive neuroendocrine tumors
Annals of Oncology Advance Access published on February 13, 2007
Ann Oncol 2007 18: 1307-1313; doi:10.1093/annonc/mdm009 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V Launay-Vacher, E Chatelut, SM Lichtman, H Wildiers, C Steer, and M Aapro

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations
Annals of Oncology Advance Access published on July 13, 2007
Ann Oncol 2007 18: 1314-1321; doi:10.1093/annonc/mdm011 [Abstract] [Full Text] [PDF] [Request Permissions]  

original articles

breast cancer

Get checked abstract M Beeram, Q-TN Tan, RR Tekmal, D Russell, A Middleton, and LA deGraffenried

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling
Ann Oncol 2007 18: 1323-1328; doi:10.1093/annonc/mdm170 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract B Klaeser, O Wiederkehr, D Koeberle, A Mueller, B Bubeck, and B Thuerlimann

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
Ann Oncol 2007 18: 1329-1334; doi:10.1093/annonc/mdm139 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S Beauclair, P Formento, JL Fischel, W Lescaut, R Largillier, E Chamorey, P Hofman, JM Ferrero, G Pagès, and G Milano

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity
Ann Oncol 2007 18: 1335-1341; doi:10.1093/annonc/mdm181 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract O Gentilini, E Botteri, N Rotmensz, M Intra, G Gatti, L Silva, N Peradze, RC Sahium, LB Gil, A Luini, P Veronesi, V Galimberti, S Gandini, A Goldhirsh, and U Veronesi

Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution
Ann Oncol 2007 18: 1342-1347; doi:10.1093/annonc/mdm182 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors

Get checked abstract G Ferrandina, M Ludovisi, R De Vincenzo, V Salutari, D Lorusso, M Colangelo, T Prantera, MR Valerio, and G Scambia

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
Annals of Oncology Advance Access published on April 29, 2007
Ann Oncol 2007 18: 1348-1353; doi:10.1093/annonc/mdm136 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract F De Vita, F Giuliani, M Orditura, E Maiello, G Galizia, N Di Martino, F Montemurro, G Cartenì, L Manzione, S Romito, V Gebbia, F Ciardiello, G Catalano, and G Colucci

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
Annals of Oncology Advance Access published on May 24, 2007
Ann Oncol 2007 18: 1354-1358; doi:10.1093/annonc/mdm128 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract J Carles, E Esteban, M Climent, A Font, JL Gonzalez-Larriba, A Berrocal, I Garcia-Ribas, X Marfa, X Fabregat, J Albanell, and J Bellmunt On behalf of Spanish Oncology Genito Urinary Group Study Group

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
Ann Oncol 2007 18: 1359-1362; doi:10.1093/annonc/mdm160 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract T El Gnaoui, J Dupuis, K Belhadj, J-P Jais, A Rahmouni, C Copie-Bergman, I Gaillard, M Diviné, I Tabah-Fisch, F Reyes, and C Haioun

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy
Annals of Oncology Advance Access published on May 11, 2007
Ann Oncol 2007 18: 1363-1368; doi:10.1093/annonc/mdm133 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract K Zervas, D Mihou, E Katodritou, A Pouli, CH Mitsouli, A Anagnostopoulos, S Delibasi, MC Kyrtsonis, N Anagnostopoulos, E Terpos, P Zikos, A Maniatis, and MA Dimopoulos On behalf of the Greek Myeloma Study Group

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group
Ann Oncol 2007 18: 1369-1375; doi:10.1093/annonc/mdm178 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S Hohaus, M Giachelia, A Di Febo, M Martini, G Massini, B Vannata, F D'Alo', F Guidi, M Greco, F Pierconti, LM Larocca, MT Voso, and G Leone

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
Annals of Oncology Advance Access published on May 11, 2007
Ann Oncol 2007 18: 1376-1381; doi:10.1093/annonc/mdm132 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract SJ Kim, BS Kim, CW Choi, J Choi, I Kim, Y-H Lee, and JS Kim

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type
Ann Oncol 2007 18: 1382-1387; doi:10.1093/annonc/mdm183 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract B Sirohi, R Powles, D Lawrence, J Treleaven, S Kulkarni, A Leary, C Rudin, C Horton, and G Morgan

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-2b in patients with multiple myeloma maintained on a steady dose of interferon-2b
Ann Oncol 2007 18: 1388-1394; doi:10.1093/annonc/mdm180 [Abstract] [Full Text] [PDF] [Request Permissions]  

palliative care

Get checked abstract L Kelly, S White, and PC Stone

The B₁₂/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study
Annals of Oncology Advance Access published on May 19, 2007
Ann Oncol 2007 18: 1395-1399; doi:10.1093/annonc/mdm138 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics

Get checked abstract S Hariharan, D Gustafson, S Holden, D McConkey, D Davis, M Morrow, M Basche, L Gore, C Zang, CL O'Bryant, A Baron, D Gallemann, D Colevas, and SG Eckhardt

Assessment of the biological and pharmacological effects of the ß₃ and ß₅ integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors
Ann Oncol 2007 18: 1400-1407; doi:10.1093/annonc/mdm140 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology

Get checked abstract MLG Janssen-Heijnen, S Houterman, VEPP Lemmens, H Brenner, EW Steyerberg, and JWW Coebergh

Prognosis for long-term survivors of cancer
Ann Oncol 2007 18: 1408-1413; doi:10.1093/annonc/mdm127 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract N Travier, M Jeffreys, N Brewer, CS Wright, CW Cunningham, J Hornell, and N Pearce

Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
Ann Oncol 2007 18: 1414-1419; doi:10.1093/annonc/mdm135 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

F Farace, C Massard, E Borghi, J-M Bidart, and J-C Soria

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells
Ann Oncol 2007 18: 1421-1422; doi:10.1093/annonc/mdm367 [Extract] [Full Text] [PDF] [Request Permissions]  

A Torresin, M Feasi, and G Cassola

Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?
Ann Oncol 2007 18: 1422-1423; doi:10.1093/annonc/mdm371 [Extract] [Full Text] [PDF] [Request Permissions]  

M Arbyn, P Autier, and J Ferlay

Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004
Ann Oncol 2007 18: 1423-1425; doi:10.1093/annonc/mdm377 [Extract] [Full Text] [PDF] [Request Permissions]  

G Ferretti, A Felici, and F Cognetti

The other side of p53
Ann Oncol 2007 18: 1425-1426; doi:10.1093/annonc/mdm398 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.